Skip to main content
Stayble Therapeutics AB (publ) (FRA:4K4)
Germany flag Germany · Delayed Price · Currency is EUR
0.0211
-0.0003 (-1.40%)
Last updated: Dec 5, 2025, 9:59 AM CET

Stayble Therapeutics AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Net Income
---23.74-24.53-12.09-15.49
Upgrade
Other Operating Activities
--0.19-0.26-0.080.17
Upgrade
Change in Accounts Receivable
---1.32-0.130.96-1.23
Upgrade
Change in Other Net Operating Assets
--1.330.031.58-7.43
Upgrade
Operating Cash Flow
---23.54-24.89-9.63-23.98
Upgrade
Investment in Securities
-----0-
Upgrade
Investing Cash Flow
-----0-
Upgrade
Long-Term Debt Issued
---0--
Upgrade
Long-Term Debt Repaid
-----0.19-0.14
Upgrade
Net Debt Issued (Repaid)
---0-0.19-0.14
Upgrade
Issuance of Common Stock
--31.82-41.5435.14
Upgrade
Other Financing Activities
---6.85--5.19-3.81
Upgrade
Financing Cash Flow
--24.96036.1531.19
Upgrade
Foreign Exchange Rate Adjustments
---0.190.260.08-0.17
Upgrade
Net Cash Flow
--1.23-24.6226.67.04
Upgrade
Levered Free Cash Flow
---15.08-15.71-5.09-18.11
Upgrade
Unlevered Free Cash Flow
---15.06-15.69-5.05-17.86
Upgrade
Change in Working Capital
--0.01-0.12.54-8.66
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.